ATE446102T1 - Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii - Google Patents

Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii

Info

Publication number
ATE446102T1
ATE446102T1 AT05292721T AT05292721T ATE446102T1 AT E446102 T1 ATE446102 T1 AT E446102T1 AT 05292721 T AT05292721 T AT 05292721T AT 05292721 T AT05292721 T AT 05292721T AT E446102 T1 ATE446102 T1 AT E446102T1
Authority
AT
Austria
Prior art keywords
patients
weight loss
inflammatory bowel
boulardii
treatment
Prior art date
Application number
AT05292721T
Other languages
English (en)
Inventor
Bernard Hublot
Herve Groux
Paul Bernasconi
Rene Levy
Guern Marie-Emmanuelle Le
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Application granted granted Critical
Publication of ATE446102T1 publication Critical patent/ATE446102T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT05292721T 2004-12-23 2005-12-16 Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii ATE446102T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/895,455 US7799328B2 (en) 2004-12-23 2004-12-23 Method for treating weight loss in patients suffering from inflammatory bowel diseases

Publications (1)

Publication Number Publication Date
ATE446102T1 true ATE446102T1 (de) 2009-11-15

Family

ID=36143315

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05292721T ATE446102T1 (de) 2004-12-23 2005-12-16 Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii

Country Status (6)

Country Link
US (1) US7799328B2 (de)
EP (1) EP1693064B1 (de)
AT (1) ATE446102T1 (de)
DE (1) DE602005017241D1 (de)
ES (1) ES2333022T3 (de)
PL (1) PL1693064T3 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876798A1 (fr) * 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
DE102007041588A1 (de) * 2007-09-01 2009-03-05 Lts Lohmann Therapie-Systeme Ag Arzneimittel mit Hefe
JP5497661B2 (ja) * 2007-12-26 2014-05-21 レサフル・エ・コンパ−ニ ヒトおよび／または動物の栄養のための組成物、その使用および酵母
FR2928652B1 (fr) * 2008-03-12 2013-11-15 Lesaffre & Cie Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
RU2427389C2 (ru) 2009-10-09 2011-08-27 Александр Владимирович Диковский Фармацевтическая композиция для профилактики и лечения инфекционных и неинфекционных диарей
FR2953412B1 (fr) * 2009-12-08 2012-04-20 Biocodex Medicament pour le traitement des ulceres gastro-intestinaux
WO2012012146A2 (en) * 2010-06-30 2012-01-26 The Regents Of The University Of Colorado Compositions and methods to modulate progression and onset of inflammatory bowel disease
IT1405757B1 (it) * 2010-11-03 2014-01-24 Gruppo Farmaimpresa Srl Preparazione farmaceutica comprendente saccaromyces e simeticone per il trattamento delle patologie gastrointestinali
EP2870969A1 (de) * 2013-11-08 2015-05-13 Biocodex Pharmazeutische Zusammensetzung zur Reduzierung der adipösen Masse
WO2016105498A1 (en) 2014-12-23 2016-06-30 Synthetic Biologics, Inc. Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
AU2020316330A1 (en) 2019-07-19 2022-01-06 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
CA3154308A1 (en) 2019-09-13 2021-03-18 Mark Smith Compositions and methods for treating autism spectrum disorder
JP2022552005A (ja) 2019-10-18 2022-12-14 フィンチ セラピューティクス ホールディングス エルエルシー 細菌代謝産物を対象に送達するための組成物および方法
WO2021097288A1 (en) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions and methods for treating neurodegenerative diseases
WO2021142353A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatitis b (hbv) and hepatitis d (hdv)
WO2021142358A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for treating hepatic encephalopathy (he)
WO2021142347A1 (en) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions and methods for non-alcoholic steatohepatitis (nash)
WO2022178294A1 (en) 2021-02-19 2022-08-25 Finch Therapeutics Holdings Llc Compositions and methods for providing secondary bile acids to a subject

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.
US4595590A (en) 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis
US4995590A (en) * 1990-05-15 1991-02-26 Close Gregg V Fence post installation
JP2001055338A (ja) * 1999-08-13 2001-02-27 Kirin Brewery Co Ltd 酵母細胞壁画分からなる薬理用組成物

Also Published As

Publication number Publication date
US7799328B2 (en) 2010-09-21
EP1693064A1 (de) 2006-08-23
ES2333022T3 (es) 2010-02-16
PL1693064T3 (pl) 2010-02-26
US20060140973A1 (en) 2006-06-29
EP1693064B1 (de) 2009-10-21
DE602005017241D1 (de) 2009-12-03

Similar Documents

Publication Publication Date Title
ATE446102T1 (de) Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii
ATE355852T1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
EP1755584A4 (de) Behandlung von myopie
ATE499934T1 (de) Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs
CY1120977T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
ATE432693T1 (de) Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden
DE602004020061D1 (de) Behandlung von autoimmunkrankheit bei einem patienten mit unzureichendem ansprechen auf einen tnf-alpha-hemmer
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE499105T1 (de) Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
EA200700427A1 (ru) Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний
DE602006017071D1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
DE602005013811D1 (de) Behandlung von fettsucht und verbundenen erkrankungen
ATE448206T1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
NO20076121L (no) Behandlinger for kardiovaskulaer sykdom
EP1742675A4 (de) Behandlung von biomedizinischem abfall
EP1796625A4 (de) Neue fenofibrat-formulierungen und relevante behandlungsmethoden
DE602006014691D1 (de) DIAGNOSE, BEHANDLUNG UND PRÄVENTION VON GEFÄSSERKRANKUNGEN MITTELS IL-1alpha-AUTOANTIKÖRPERN
EP1543158A4 (de) Regulierte aptamer-therapeutika
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
ATE400297T1 (de) Ctgf als zielmolekül in der behandlung von mikroalbuminurie in patienten mit diabetischer nephropathie
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
ATE448785T1 (de) Behandlung von entzündlicher darmerkrankung
DK1596879T3 (da) Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties